The 1H3.SI stock closed the Singapore Exchange (SES) session on 27 Mar 2026 at S$0.001, down 50.0% from the prior close as average and intraday liquidity tightened. Trading volume spiked to 10,001,800 shares, well above the 50-day average. This fall places Clearbridge Health Limited (1H3.SI) among the top losers of the day on the SES. We examine what moved the share price, how the healthcare sector context matters, and what the data imply for short-term traders and longer-term investors using Meyka AI-powered market analysis.
Why 1H3.SI stock fell 50% on 27 Mar 2026
The price drop to S$0.001 followed a one-day decline of -50.0%, with the stock trading between S$0.001 and S$0.001 on the session. One large block trade and thin order books magnified the move, turning modest sell pressure into a steep intraday fall. The company has no public EPS figure and limited liquidity, which increases sensitivity to single large orders.
Trading snapshot and liquidity metrics
Volume surged to 10,001,800 versus a 3‑month average of 3,972,267, showing a relative volume spike that amplified volatility. Market capitalisation stands at S$4,295,821, with 4,295,820,825 shares outstanding, so even small cash flows can swing the price materially. Low price averages—50‑day S$0.00192 and 200‑day S$0.00247—confirm persistent thin trading.
Valuation and key financial ratios for Clearbridge Health
On accounting metrics the stock shows a price‑to‑sales ratio of 0.43 and price‑to‑book near 0.95, with trailing net income per share negative at -0.00391. Current ratio is 1.51 and debt‑to‑equity is 0.42, signalling modest leverage. These ratios reflect a small healthcare holding company with constrained profitability and mixed balance sheet signals.
Meyka AI rates 1H3.SI with a score out of 100
Meyka AI rates 1H3.SI with a score out of 100: 61.97 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade balances weak earnings metrics against low market cap and potential upside in scenario forecasts. These grades are not guarantees and we are not financial advisors.
Technical picture and sector context
Technically the stock shows an RSI of 42.13 and a strong ADX at 49.35, indicating a strong trend but indecisive momentum. Healthcare sector peers trade at an average PE of 21.22, making Clearbridge’s negative PE and small scale an outlier. Sector strength is mixed; investors often prefer larger healthcare chains with steadier margins.
Risks, catalysts and analyst outlook for 1H3.SI stock
Key risks include thin liquidity, negative earnings per share, and dependence on regional clinic operations. Catalysts that could stabilise the stock: clearer earnings guidance, larger institutional interest, or a corporate action that improves free float. For recent comparative data see a peer comparison on Investing.com source.
Final Thoughts
Clearbridge Health (1H3.SI stock) closed the SES session on 27 Mar 2026 at S$0.001, down 50.0% on heavy volume, putting the company firmly among the day’s top losers. The move reflects thin liquidity and negative profitability metrics rather than a clear change in operating fundamentals. Meyka AI’s forecast model projects a one‑year target near S$0.005, implying roughly 400.00% potential upside from today’s price; forecasts are model‑based projections and not guarantees. Our view: short‑term traders face high volatility and liquidity risk, while longer‑term investors should look for improved earnings visibility and higher average daily turnover before re‑entering. The stock’s B grade from Meyka AI (score 61.97) balances downside risks and modelled upside but is not investment advice.
FAQs
What drove the 50% fall in 1H3.SI stock on 27 Mar 2026?
A combination of thin order books and one or more large sell trades pushed 1H3.SI stock to S$0.001. Volume jumped to 10,001,800, amplifying moves. There was no linked EPS update; the drop mainly reflects liquidity and market microstructure.
What is Meyka AI’s view on 1H3.SI stock performance?
Meyka AI assigns 1H3.SI a B grade with a score of 61.97, suggesting a HOLD. The grade balances weak fundamentals and low liquidity against scenario upside in the model. Grades are informational and not recommendations.
Does 1H3.SI stock have positive earnings or a clear price target?
Clearbridge reports negative net income per share; EPS is N/A publicly. Meyka AI’s model projects a one‑year scenario near S$0.005, but this is a forecast, not a guarantee. Watch liquidity before trading.
How should investors approach the 1H3.SI stock volatility?
Treat 1H3.SI stock as high risk due to low price, small market cap and thin liquidity. Use limit orders, check average volume, and prefer position sizing that limits exposure to sudden moves. Confirm any company announcements before acting.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)